International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 October 2014

Summary

 

IBT Portfolio NAV (m)

224

Number of Portfolio Companies

83

Quoted Investments

59

Unquoted Investments

24

 

Quoted / Unquoted Split
NAV by Geography

Quoted

93%

United States / Canada

88%

Unquoted

7%

Europe

12%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

78%

Large-Cap (>$10bn)

55%

Medical Devices

4%

Mid-Cap (>$1bn, <$10bn)

31%

Specialty Pharma

12%

Small-Cap (<$1bn)

7%

Life Sciences, Tools

6%

Unquoted

7%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

67%

Profitable

57%

Regulatory

8%

Turning Profitable 2014

7%

Phase 3

17%

Unprofitable

36%

Phase 2

9%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%